跳至主要内容
临床试验/NCT01380886
NCT01380886已完成3 期

Growth and Tolerance of Young Infants Fed Infant Formulas

Abbott Nutrition12 个研究点 分布在 1 个国家目标入组 209 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
209
试验地点
12
主要终点
Weight gain

研究概览

简要总结

This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 8 Days(Child)
性别
All
接受健康志愿者
是

入选标准

  • •healthy infant
  • •full term
  • •birth weight > 2490 g
  • •0 to 8 days of age
  • •parent/physician agree to not use medications affecting tolerance/growth
  • •parent agrees to sole source feeding of study formula
  • •parent agrees to not use vitamin/mineral supplements
  • •parent has signed consent/HIPAA authorization

排除标准

  • •any maternal, fetal, or infant history affecting growth and tolerance
  • •participation in any other study not preapproved by Abbott

研究组 & 干预措施

Infant formula, alternate protein source

Experimental

Experimental infant formula with alternate protein source

干预措施: experimental infant formula with alternate protein source (Other)

Infant formula powder

Active Comparator

Infant formula powder

干预措施: Infant formula powder (Other)

结局指标

主要结局

Weight gain

时间窗: 119 days

次要结局

  • gastrointestinal tolerance(119 days)
  • Anthropometric variables(119 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验